$2.16 -0.04 (%) Brainstorm Cell Therapeutics Inc - NASDAQ

Dec. 9, 2016 | 03:56 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Interview With Neurologist And ALS KOL Sheds Light On Brainstorm's Potential With NurOwn

    TalkMarkets | Nov. 28, 2016 | 13:05PM EST
  2. Brainstorm Cell Therapeutics ALS Trial Shows Stem Cell Treatment Inhibits Disease Progression in 87% of Patients

    Benzinga | Jan. 11, 2016 | 18:44PM EST
  3. Mid-Morning Market Update: Markets Open Higher; Shire To Acquire Baxalta For $32B

    Benzinga | Jan. 11, 2016 | 10:07AM EST
  4. BrainStorm Cell Therapeutics Names Dr. Revital Geffen-Aricha as VP of R&D

    Benzinga | Dec. 7, 2015 | 04:07AM EST
  5. BrainStorm and Octane Biotech Announce Success in Cocoon Application Development Based on Customized Bioreactor for NurOwn® Stem Cells

    Benzinga | Dec. 1, 2015 | 08:10AM EST
  6. BrainStorm Awarded Additional $735K Non-Dilutive Grant for 2015 from Israel's Office of the Chief Scientist

    Benzinga | Nov. 30, 2015 | 04:10AM EST
  7. BrainStorm Announces Treatment of Final Patient in US Multicenter Double Blinded Phase 2 ALS Trial

    Benzinga | Oct. 7, 2015 | 08:37AM EST
  8. UPDATE: BrainStorm Cell Therapeutics Reports Closing of Enrollment in Phase 2 Trial of NurOwn in ALS

    Benzinga | Aug. 11, 2015 | 07:09AM EST
  9. Morning Market Gainers

    Benzinga | Apr. 14, 2015 | 08:42AM EST
  10. BrainStorm Cell Therapeutics to Present Positive NurOwn® Phase 2a Clinical Data

    Benzinga | Apr. 14, 2015 | 06:02AM EST
  11. What Investors Are Looking At In The Stem Cell Sector

    Benzinga | Jan. 13, 2015 | 11:48AM EST
  12. Morning Market Losers

    Benzinga | Jan. 5, 2015 | 09:57AM EST
  13. Monday #PreMarket Movers: Conatus Pharmaceuticals, Brainstorm Cell Therapeutics And More

    Benzinga | Jan. 5, 2015 | 09:31AM EST
  14. Stocks Hitting 52-Week Highs

    Benzinga | Jan. 2, 2015 | 10:18AM EST
  15. Morning Market Movers

    Benzinga | Jan. 2, 2015 | 09:39AM EST
  16. Brainstorm Cell Therapeutics Soars 45%

    Benzinga | Jan. 2, 2015 | 08:57AM EST
  17. Benzinga's Top #PreMarket Gainers

    Benzinga | Jan. 2, 2015 | 08:38AM EST
Trading Center